Multi-cancer detection test study at Mayo Clinic
Treatments studied
Part of Cancer clinical trials.
This study will collect blood samples from people who have had or are scheduled to have a multi-cancer detection test. Researchers want to learn more about how well these tests work and how the results affect follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older.
- You have a Mayo Clinic medical record number.
- You had a multi-cancer detection test in the last 6 months, or you are scheduled to have one.
- You are willing and able to give a blood sample.
- You are not currently being treated for cancer (except hormone therapy).
- You have not been diagnosed with invasive cancer in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, saliva, tumor tissue, or hair samples to look for inherited and tumor-related gene changes that may explain your cancer, guide prevention, or help find better treatments. You can join if you are a Mayo Clinic patient with cancer and your doctor has ordered genetic testing.
This study tests a blood test that looks for signs of cancer early in people without symptoms. It aims to see how well the test works in real-world settings.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study is testing a new blood test that may help find multiple types of cancer early. It compares blood samples from people with newly diagnosed cancer to those without cancer.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.